Natera Shares Are Trading Higher After the Company Announced the Publication of Three Peer-reviewed Papers, Resulting in Over 85 Peer-reviewed Publications on Its Cancer Diagnostic Test Signatera
Natera Shares Are Trading Higher After the Company Announced the Publication of Three Peer-reviewed Papers, Resulting in Over 85 Peer-reviewed Publications on Its Cancer Diagnostic Test Signatera
natera股價上漲，公司宣佈發表了三篇同行評議論文，使其癌症診斷檢測Signatera的同行評議文章超過85篇。
Natera Shares Are Trading Higher After the Company Announced the Publication of Three Peer-reviewed Papers, Resulting in Over 85 Peer-reviewed Publications on Its Cancer Diagnostic Test Signatera
natera股價上漲，公司宣佈發表了三篇同行評議論文，使其癌症診斷檢測Signatera的同行評議文章超過85篇。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。